glp-1 discontinuation rates Bariatric Surgery vs Weight Loss Medications (Wegovy & ZepBound) November Blog - What happens

Our study showed no differences for VitD and OCN at baseline between those with osteoporosis and without osteoporosis at follow-up

OBJECTIVES: After completing this activity, the participant should be able to: Describe DPP-4 inhibitors' mechanism of action in lowering blood glucose concentrations in patients with type 2 diabetes

Most of that water gets absorbed in the upper GI tract and never reaches your colon

Beyond improving health, these medications enhance quality of life and lower the risk of life-threatening events, including strokes, heart failure, and all-cause mortality

Once you reach your goal weight on a GLP-1, you may be interested in lowering your dose

Orforglipron was FDA approved in April 2026